Kwarteng, A., Asiedu, E., Sylverken, A., Larbi, A., Mubarik, Y., & Apprey, C. (2021). In silico drug repurposing for filarial infection predicts nilotinib and paritaprevir as potential inhibitors of the Wolbachia 5′-aminolevulinic acid synthase. Nature Portfolio.
Style de citation Chicago (17e éd.)Kwarteng, Alexander, Ebenezer Asiedu, Augustina Sylverken, Amma Larbi, Yusif Mubarik, et Charles Apprey. In Silico Drug Repurposing for Filarial Infection Predicts Nilotinib and Paritaprevir as Potential Inhibitors of the Wolbachia 5′-aminolevulinic Acid Synthase. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Kwarteng, Alexander, et al. In Silico Drug Repurposing for Filarial Infection Predicts Nilotinib and Paritaprevir as Potential Inhibitors of the Wolbachia 5′-aminolevulinic Acid Synthase. Nature Portfolio, 2021.